AAAAAA

   
Results: 1-17 |
Results: 17
Determinants of HIV-1 shedding in the genital tract of women
Authors: Kovacs, A Wasserman, SS Burns, D Wright, DJ Cohn, J Landay, A Weber, K Cohen, M Levine, A Minkoff, H Miotti, P Palefsky, J Young, M Reichelderfer, P
Citation: A. Kovacs et al., Determinants of HIV-1 shedding in the genital tract of women, LANCET, 358(9293), 2001, pp. 1593-1601
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915
Authors: Wang, JY Pasetti, MF Noriega, FR Anderson, RJ Wasserman, SS Galen, JE Sztein, MB Levine, MM
Citation: Jy. Wang et al., Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915, INFEC IMMUN, 69(8), 2001, pp. 4734-4741
Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection
Authors: Kotloff, KL Sztein, MB Wasserman, SS Losonsky, GA DiLorenzo, SC Walker, RI
Citation: Kl. Kotloff et al., Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection, INFEC IMMUN, 69(6), 2001, pp. 3581-3590
Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults
Authors: Kotloff, KL Wasserman, SS Losonsky, GA Thomas, W Nichols, R Edelman, R Bridwell, M Monath, TP
Citation: Kl. Kotloff et al., Safety and immunogenicity of increasing doses of a Clostridium difficile toroid vaccine administered to healthy adults, INFEC IMMUN, 69(2), 2001, pp. 988-995
Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C
Authors: Tacket, CO Galen, J Sztein, MB Losonsky, G Wyant, TL Nataro, J Wasserman, SS Edelman, R Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C, CLIN IMMUNO, 97(2), 2000, pp. 146-153
Vibrio cholerae ACE stimulates Ca2+-dependent Cl-/HCO3- secretion in T84 cells in vitro
Authors: Trucksis, M Conn, TL Wasserman, SS Sears, CL
Citation: M. Trucksis et al., Vibrio cholerae ACE stimulates Ca2+-dependent Cl-/HCO3- secretion in T84 cells in vitro, AM J P-CELL, 279(3), 2000, pp. C567-C577
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections
Authors: Plaisance, KI Kudaravalli, S Wasserman, SS Levine, MM Mackowiak, PA
Citation: Ki. Plaisance et al., Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections, PHARMACOTHE, 20(12), 2000, pp. 1417-1422
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
Authors: Richie, E Punjabi, NH Sidharta, Y Peetosutan, K Sukandar, M Wasserman, SS Lesmana, M Wangsasaputra, F Pandam, S Levine, MM O'Hanley, P Cryz, SJ Simanjuntak, CH
Citation: E. Richie et al., Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area, VACCINE, 18(22), 2000, pp. 2399-2410
Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract
Authors: Baron, P Bremer, J Wasserman, SS Nowicki, M Driscoll, B Polsky, B Kovacs, A Reichelderfer, PS
Citation: P. Baron et al., Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract, J CLIN MICR, 38(10), 2000, pp. 3822-3824
Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers
Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201
Phase II safety and immunogenicity study of live chikungunya virus vaccineTSI-GSD-218
Authors: Edelman, R Tacket, CO Wasserman, SS Bodison, SA Perry, JG Mangiafico, JA
Citation: R. Edelman et al., Phase II safety and immunogenicity study of live chikungunya virus vaccineTSI-GSD-218, AM J TROP M, 62(6), 2000, pp. 681-685
Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers
Authors: Lagos, R San Martin, O Wasserman, SS Prado, V Losonsky, GA Bustamante, C Levine, MM
Citation: R. Lagos et al., Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers, PEDIAT INF, 18(7), 1999, pp. 624-630
Hepatitis B vaccination of premature infants: A reassessment of current recommendations for delayed immunization
Authors: Losonsky, GA Wasserman, SS Stephens, I Mahoney, F Armstrong, P Gumpper, K Dulkerian, S West, DJ Gewolb, IH
Citation: Ga. Losonsky et al., Hepatitis B vaccination of premature infants: A reassessment of current recommendations for delayed immunization, PEDIATRICS, 103(2), 1999, pp. E141-E147
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR
Authors: Lagos, R Fasano, A Wasserman, SS Prado, V Martin, OS Abrego, P Losonsky, GA Alegria, S Levine, MM
Citation: R. Lagos et al., Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR, J INFEC DIS, 180(5), 1999, pp. 1709-1712
Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama
Authors: Taylor, DN Sanchez, JL Castro, JM Lebron, C Parrado, CM Johnson, DE Tacket, CO Losonsky, GA Wasserman, SS Levine, MM Cryz, SJ
Citation: Dn. Taylor et al., Expanded safety and immunogenicity of a bivalent, oral, attenuated choleravaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama, INFEC IMMUN, 67(4), 1999, pp. 2030-2034
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination
Authors: Tacket, CO Cohen, MB Wasserman, SS Losonsky, G Livio, S Kotloff, K Edelman, R Kaper, JB Cryz, SJ Giannella, RA Schiff, G Levine, MM
Citation: Co. Tacket et al., Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El Tor Inaba threemonths after vaccination, INFEC IMMUN, 67(12), 1999, pp. 6341-6345
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA
Authors: Galen, JE Nair, J Wang, JK Wasserman, SS Tanner, MK Sztein, MB Levine, MM
Citation: Je. Galen et al., Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA, INFEC IMMUN, 67(12), 1999, pp. 6424-6433
Risultati: 1-17 |